All resolutions passed at GM of Tissue Regenix

Writer, Stock Market Wire
Tuesday, August 8, 2017 - 13:51

Tissue Regenix Group has confirmed that all resolutions, including those in respect of the Offer and Acquisition announced by the Company on 20 July, were passed by shareholders at today's General Meeting.

Accordingly, the Company has applied to the London Stock Exchange for 400,000,000 New Ordinary Shares to be admitted to trading on AIM, which is expected to occur at 8.00 a.m. on 9 August.

At 1:51pm: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 11.5p

Related content

Tissue Regenix signs 10-year lease on facility in US to ramp up processing capacity

Medical devices group Tissue Regenix signed a 10-year lease agreement on a facility to expand processing capacity at its manufacturing base in San Antonio, Texas....

Thu, 15/08/2019 - 08:46

CEO Steve Couldwell resigns from Tissue Regenix due to illness

Regenerative medical devices company Tissue Regenix Group said that CEO Steve Couldwell had resigned his position 'with immediate effect' due to a recurrence of illness....

Thu, 01/08/2019 - 09:45

Tissue Regenix secures $20m in loan facilities

Regenerative medical devices company Tissue Regenix Group said some of its subsidiaries had agreed with MidCap Financial Trust to access a revolving credit facility and...

Tue, 04/06/2019 - 07:31

Tissue Regenix CEO to return to full-time duties after medical treatment

Regenerative medical devices company Tissue Regenix Group said chief executive Steve Couldwell would return to full time duties during June.

Couldwell had taken a leave...

Tue, 21/05/2019 - 08:25

Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48